about
Cost-effectiveness in the management of patients with oesophageal cancer.Mid-esophagus unresectable cancer treated with a low cost stent. First experience.Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer.Quality of life measurement in patients with oesophageal cancer.Positron Emission Tomography (PET) in Oncology[Curietherapy in the palliative treatment of esophageal cancer].SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α SignalingPhase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancerCost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer.A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.Antireflux versus conventional self-expanding metallic Stents (SEMS) for distal esophageal cancer: results of a multicenter randomized trial.Anti-ERBB2 sh-RNA suppress both cell growth and tumor growth in ERBB2-overexpressing upper gastrointestinal adenocarcinomasMinimally Invasive Esophagectomy Utilizing a Stapled Side-to-Side Anastomosis is Safe in the Western Patient Population.The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.Superiority of anti-reflux stent compared with conventional stents in the palliative management of patients with cancer of the lower esophagus and esophago-gastric junction: results of a randomized clinical trial.Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation.Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivo.Current challenges for outcome measurement in surgical practice.Cancer of the oesophagus.Primary melanoma of the oesophagus well palliated by radiotherapy.S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trial.Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis.Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer.Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers.Effects of S-1 combined with radiotherapy in the treatment of advanced esophageal cancer: A systematic review and meta-analysis protocol.UEG Week 2015 Poster Presentations
P2860
Q31995669-09F3E3DC-DA12-4609-966C-4B0D52922D64Q34072456-BE3CFD53-C39E-403B-8D49-9B89C8626B08Q34190498-10EC6BB8-F22B-41FA-A8FB-B0D88E965355Q34408995-4EEC604B-B6AD-4B90-AFCB-F80E60767BFBQ34774840-E2E34B40-B083-43A7-9C81-CD9FDE36383EQ35668157-D3C7A980-8D24-4C0A-B884-05680D709ECEQ36184138-3F63CD69-E27F-443A-A05D-06ABD8E0CBD1Q36609800-DC9E15C5-18A3-496B-884D-6CD3734A37B0Q36694186-29B3AC74-9CF9-4E68-A573-F82430368919Q37038184-2429B21B-D3EA-4599-9F0F-9CB5409012F9Q37195156-03E28467-DD16-454F-A350-07442572E588Q37390655-24466032-D5C2-4DCF-9F12-90F17BC675AFQ38817049-09253149-1C7E-408F-B66C-3C0589329FAEQ39096931-5DF896D0-27FB-40CF-8973-EA63527AAD6CQ39328670-FFB7712B-35DC-43C4-98C6-3E37B1DD3ADEQ40529900-843B181E-D85A-4262-B314-8F5E3292CFEDQ40591975-659FA915-92E0-44DC-A54C-69E05E82AB21Q41594319-784A8509-435D-42EF-8600-3EE39DAA583CQ43225356-6440BB55-0720-409B-A982-3A82E5FCF85CQ45166498-4E36C996-B0AA-47DF-869A-8787E343EF09Q47129248-5E7648C4-98BF-4287-B941-19489111F358Q47718962-09B8F27B-17F1-4139-9FF1-87A312F26A84Q49147470-626CF4C2-E82B-4701-8798-88F3AA30DD90Q49168859-50BB81FD-4A26-48A7-BEC8-BE887FC666C8Q50697375-91DD3BFA-DC70-4D10-AC04-1198E252B4CAQ55344925-8B8E2E9A-0F9F-47AF-AE96-0C23390C3F19Q56934656-8483C818-369D-4C26-9F88-5F2FE1D7F986
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
An audit of the treatment of cancer of the oesophagus.
@ast
An audit of the treatment of cancer of the oesophagus.
@en
An audit of the treatment of cancer of the oesophagus.
@nl
type
label
An audit of the treatment of cancer of the oesophagus.
@ast
An audit of the treatment of cancer of the oesophagus.
@en
An audit of the treatment of cancer of the oesophagus.
@nl
prefLabel
An audit of the treatment of cancer of the oesophagus.
@ast
An audit of the treatment of cancer of the oesophagus.
@en
An audit of the treatment of cancer of the oesophagus.
@nl
P2093
P2860
P356
P1433
P1476
An audit of the treatment of cancer of the oesophagus.
@en
P2093
P2860
P304
P356
10.1136/GUT.35.7.941
P407
P577
1994-07-01T00:00:00Z